Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial
Nisa Laohapojanart, Chaveewan Ratanajamit, Kamon Kawkitinarong, Teerapol Srichana
Topics & Concepts
MedicinePyrazinamideDry-powder inhalerIsoniazidLevofloxacinRifampicinCulture conversionInternal medicineTuberculosisPlaceboRandomized controlled trialAdverse effectSputumIntention-to-treat analysisSurgeryAntibioticsInhalerPathologyAsthmaMicrobiologyAlternative medicineBiologyInhalation and Respiratory Drug DeliveryTuberculosis Research and EpidemiologyAsthma and respiratory diseases